Pittsburgh based ALung Technologies won the European CE Mark to begin introducing the Hemolung Respiratory Assist System (RAS). The device, intended for people suffering from acute lung failure, performs the essential duties of a lung, removing CO2 from blood and oxygenating it. The partial respiratory support takes the load off the organ and gives it a chance to heal.
The procedure is similar to renal dialysis, with a venous catheter used to pass the blood to and from the Hemolung.
From the product page:
- Extraordinary CO2 removal at blood flow rates of 350 – 550 mL/min for rapid correction of hypercapnia.
- Requires only one 15.5 Fr venous catheter (jugular or femoral percutaneous insertion).
- Simple, closed extracorporeal circuit and continuous monitoring simplify therapy delivery.
Flashbacks: Hemolung, a Respiratory Dialysis Device, to Start Clinical Trials; Hemolung Respiratory Dialysis System May Soon Replace Ventilation for Critically Ill in Europe
Product page: Hemolung Respiratory Assist System…
Press release: ALung Technologies Receives CE Mark Approval for Hemolung Respiratory Assist System